BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 17325299)

  • 1. SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease.
    Bang H; Vupputuri S; Shoham DA; Klemmer PJ; Falk RJ; Mazumdar M; Gipson D; Colindres RE; Kshirsagar AV
    Arch Intern Med; 2007 Feb; 167(4):374-81. PubMed ID: 17325299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension in early-stage kidney disease: an update from the Kidney Early Evaluation Program (KEEP).
    Kalaitzidis R; Li S; Wang C; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S22-31. PubMed ID: 19285608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).
    Whaley-Connell A; Sowers JR; McCullough PA; Roberts T; McFarlane SI; Chen SC; Li S; Wang C; Collins AJ; Bakris GL;
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S11-21. PubMed ID: 19285607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.
    Whaley-Connell AT; Sowers JR; Stevens LA; McFarlane SI; Shlipak MG; Norris KC; Chen SC; Qiu Y; Wang C; Li S; Vassalotti JA; Collins AJ;
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S13-20. PubMed ID: 18359403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease.
    Stevens LA; Fares G; Fleming J; Martin D; Murthy K; Qiu J; Stark PC; Uhlig K; Van Lente F; Levey AS
    J Am Soc Nephrol; 2005 Aug; 16(8):2439-48. PubMed ID: 15930090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening populations at increased risk of CKD: the Kidney Early Evaluation Program (KEEP) and the public health problem.
    Vassalotti JA; Li S; Chen SC; Collins AJ
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S107-14. PubMed ID: 19231754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease.
    Collins AJ; Vassalotti JA; Wang C; Li S; Gilbertson DT; Liu J; Foley RN; Chen SC; Arneson TJ
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S71-7. PubMed ID: 19231764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004.
    Vassalotti JA; Uribarri J; Chen SC; Li S; Wang C; Collins AJ; Calvo MS; Whaley-Connell AT; McCullough PA; Norris KC;
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S56-68. PubMed ID: 18359409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between glomerular filtration rate and the prevalence of metabolic abnormalities: results from the Third National Health and Nutrition Examination Survey (NHANES III).
    Clase CM; Kiberd BA; Garg AX
    Nephron Clin Pract; 2007; 105(4):c178-84. PubMed ID: 17347576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004.
    Rao MV; Qiu Y; Wang C; Bakris G
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S30-7. PubMed ID: 18359406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment in glomerular filtration rate or glomerular filtration barrier and occurrence of stroke.
    Ovbiagele B
    Arch Neurol; 2008 Jul; 65(7):934-8. PubMed ID: 18625861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The screening for Occult Renal Disease (SCORED) value is associated with a higher risk for having or developing chronic kidney disease in patients treated for small, unilateral renal masses.
    Lucas SM; Nuss G; Stern J; Lotan Y; Sagalowsky AI; Cadeddu JA; Raj GV
    Cancer; 2008 Nov; 113(10):2681-6. PubMed ID: 18853420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and associations of anemia of CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.
    McFarlane SI; Chen SC; Whaley-Connell AT; Sowers JR; Vassalotti JA; Salifu MO; Li S; Wang C; Bakris G; McCullough PA; Collins AJ; Norris KC;
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S46-55. PubMed ID: 18359408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The accuracy of cystatin C and commonly used creatinine-based methods for detecting moderate and mild chronic kidney disease in diabetes.
    Macisaac RJ; Tsalamandris C; Thomas MC; Premaratne E; Panagiotopoulos S; Smith TJ; Poon A; Jenkins MA; Ratnaike SI; Power DA; Jerums G
    Diabet Med; 2007 Apr; 24(4):443-8. PubMed ID: 17388960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan.
    Iseki K; Kinjo K; Iseki C; Takishita S
    Am J Kidney Dis; 2004 Nov; 44(5):806-14. PubMed ID: 15492946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.
    Malyszko J; Bachorzewska-Gajewska H; Sitniewska E; Malyszko JS; Poniatowski B; Dobrzycki S
    Ren Fail; 2008; 30(6):625-8. PubMed ID: 18661413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000.
    Coresh J; Byrd-Holt D; Astor BC; Briggs JP; Eggers PW; Lacher DA; Hostetter TH
    J Am Soc Nephrol; 2005 Jan; 16(1):180-8. PubMed ID: 15563563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality.
    McCullough PA; Li S; Jurkovitz CT; Stevens L; Collins AJ; Chen SC; Norris KC; McFarlane S; Johnson B; Shlipak MG; Obialo CI; Brown WW; Vassalotti J; Whaley-Connell AT; Brenner RM; Bakris GL;
    Am Heart J; 2008 Aug; 156(2):277-83. PubMed ID: 18657657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.